Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric oxygen for Long COVID syndrome
NCT04842448Phase 2Completed
- Sponsor
- Karolinska University Hospital
- Start
- Sep 2021
- Primary completion
- Sep 2023
- Modality
- NPI (Non-Pharmacological Intervention)
- Countries
- 1
01
Overview
A Phase 2 trial of hyperbaric oxygen therapy in Post COVID-19 Syndrome (PCS), sponsored by Karolinska University Hospital. Started Sep 2021; status: completed.
02
Drugs
hyperbaric oxygen therapy
03
Conditions
Post COVID-19 Syndrome (PCS)
Beyond the preview
Go deeper on NCT04842448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04842448.